Experimental Determination of Atot en Ka in the Critically Ill
NCT01928745 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2014-05-20
Summary
To diagnose acid base disturbances using blood gas analysis, multiple approaches are currently in use. These include the classic Henderson-Hasselbach bicarbonate approach and the physiochemical approach by Stewart1. All have shown to be mathematically compatible2.
Diagnosing the metabolic component of acid base disturbances relies on the assessment of the so called ion gaps: the anion gap for the classic acid-base approach and the strong ion difference (SID) for the Stewart approach. This gap may unveil unidentified anions to provide a more accurate diagnosis. In particular they allow differentiating between relative hyperchloremia and other strong ions such as lactate, ketones, salicylates, citrate and ethylene glycol3.
The accuracy of both gaps relies on the estimation of the weak acid dissociation: A-. This A- is dependent on the total concentration of weak acids (Atot) of which albumin is the most important and the effective dissociation constant for these (Ka), which determines the dissociated fraction of the Atot. This dissociation fraction needs to be accounted for in the ion gaps. This is reflected in the recommendation to correct the anion gap for albumin and incorporated in the SID which includes a factor for albumin by design3,4. However, the correction factor for albumin is currently based on data from animals and healthy volunteers4-9. In the critically ill albumin and protein content are very different compared to healthy volunteers, most notably in sepsis. Further, it is unknown if subunit composition of albumin is different in these patients. In addition, different protein species may be either up or downregulated in the critically ill1,8,9.Therefore from a pathophysiological point of view Atot and Ka and thus A- may differ in the critically ill. However it has not been previously investigated if and to what extent these matters affect Atot and Ka and therefore A- in this population.
In addition, previous studies looking into this values showed a higher than expected value of unmeasured anions from the gap calculations. Despite rigorous experimental effort including high performance liquid chromatography, the origin of these unmeasured anions have not yet been elucidated17-20. However if the assumptions made in the Stewarts approach would not be valid, the existence of these unknown anions may have to be questioned.
Thus it is of great interest to experimentally determine the exact contribution of the weak acids and their dissociation in sepsis. This could have major implications for these patients because different assumptions will ultimately lead to alterations in their calculated anion gap or SID. This may reduce unnecessary diagnostic test, alter final diagnosis and hence alter therapy.
In this study the investigators aim to experimentally determine the Atot and Ka and thus their dissociated fraction A- in critically ill septic patients admitted to the intensive care unit by using in vitro CO2 tonometry, plasma dialysis and Marquardt regression analysis. In addition, as a control the investigators will do the same for patients admitted to the intensive care after routine cardiac surgery. Furthermore Atot and Ka values for both groups will be compared to values obtained from human volunteers in a previous study4.
To achieve this, the investigators will plot CO2 versus pH titration curves from plasma samples of these patients. The investigators will then use Marquardt nonlinear regression analysis to quantify Atot and Ka and the SID by simultaneously solving for these parameters21. To make the quantification for Atot and Ka more robust, the investigators will also perform the same experiments after dialyzing the obtained plasma samples against a crystalloid solution of known composition in order to eliminate errors related to estimation of the SID. Finally, Atot and Ka values for both groups will be compared to values obtained from human volunteers in a previous study4. For application in the bicarbonate and base excess centred frameworks, Atot and Ka values will be related to albumin and protein content to update the correction factor for the anion gap in critically ill.
Conditions
- Sepsis
- CABG
Sponsors & Collaborators
-
Amsterdam UMC, location VUmc
lead OTHER
Principal Investigators
-
P WG Elbers, MD, PhD · Amsterdam UMC, location VUmc
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Effects of Fluid Balance Control in Critically Ill Patients
NCT02765009 ·Status: COMPLETED ·Phase: NA
-
Timing and Dose of Fluid Deresuscitation in Critically Ill Patients
NCT07275658 ·Status: RECRUITING
-
Prospective Data Analysis of the Development of Hypernatremia in Intensive Care Unit
NCT03752450 ·Status: COMPLETED
-
Sodium Bicarbonate for the Treatment of Severe Metabolic Acidosis With Moderate or Severe Acute Kidney Injury in ICU
NCT04010630 ·Status: COMPLETED ·Phase: NA
-
High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy
NCT03846258 ·Status: WITHDRAWN ·Phase: PHASE4
-
Assessment of Electrolyte Values in the Intensive Care Unit:Comparison Between Arterial and Venous Blood Gas Analysis and Formal Laboratory Testing
NCT00256061 ·Status: WITHDRAWN
-
Lactate Metabolism in the Hypoperfused Critically Ill
NCT05582824 ·Status: UNKNOWN
-
Accuracy of Point-of-Care Measurement With the RapidPoint 500 Blood Gas Analyser
NCT02449226 ·Status: COMPLETED
-
Colloid Osmotic Pressure and Osmolality in Hyponatremia
NCT03703713 ·Status: TERMINATED
-
Acid Base Balance of ICU Patients With Severe Hypoalbuminemia, Before and After an Albumin Infusion, Using Stewart Approach
NCT02288494 ·Status: UNKNOWN
-
Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy (SBT) in Critically Ill Patients
NCT04953013 ·Status: COMPLETED
-
Intravenous Bicarbonate To Verify The Correct Position of IV Catheters in Oncological Patients Oncological Patients Receiving Chemotherapy
NCT01748097 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Investigation of Fluid- and Electrolyte Balance in Post Cardiac-surgery Patients
NCT02914782 ·Status: COMPLETED
-
Fluid Responsiveness Prediction at the Bedside
NCT00721604 ·Status: COMPLETED
-
Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill
NCT02476253 ·Status: COMPLETED ·Phase: PHASE3
-
Fluid Kinetics in Patients With Diabetic Ketoacidosis
NCT02172092 ·Status: COMPLETED ·Phase: NA
-
Once Versus Twice Daily Electrolyte Monitoring in CHF
NCT02497742 ·Status: COMPLETED ·Phase: NA
-
Prospective Analysis Into Development of Hypernatremia in Critically Ill Patients
NCT05085223 ·Status: UNKNOWN
-
Perioperative Fluid Management in Patients Receiving Cadaveric Renal Transplants
NCT01075750 ·Status: COMPLETED
-
Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation
NCT05909150 ·Status: RECRUITING ·Phase: PHASE2
-
Kinetic Method to Detect Dehydration
NCT01062776 ·Status: COMPLETED ·Phase: PHASE1
-
Balanced Solution Versus Saline in Intensive Care Study
NCT02875873 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of 5% Nacl and 10% NaHCO3 As Contrast Agents for Lung Perfusion with EIT
NCT06868810 ·Status: COMPLETED ·Phase: NA
-
Isotonic Solutions and Major Adverse Renal Events Trial in the Medical Intensive Care Unit
NCT02444988 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Potassium Targets Within the Normal Range in Intensive Care Patients
NCT01085071 ·Status: COMPLETED ·Phase: PHASE4